Publicaties 2004
Hieronder vindt u de publicaties van de vakgroep Farmaceutische Biologie in 2004. Indien u op een artikel klikt, dan wordt u (indien mogelijk) automatisch naar het artikel doorgelinked.
Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Westers L, Westers H, Quax WJ. Biochim Biophys Acta. 2004 Nov 11;1694(1-3):299-310.
Seifar RM, Cool RH, Quax WJ, Bischoff R. Electrophoresis. 2004 Jun;25(10-11):1561-8.
Chemical characterisation of three haemolytic compounds from the microalgal species Fibrocapsa japonica (Raphidophyceae). Fu, M., Koulman, A., van Rijssel, M., Lützen, A., de Boer, M.K., Tyl, M.R., Liebezeit, G. Toxicon 43(4):355-63.
Comparison and functional characterisation of three homologous intracellular carboxylesterases of Bacillus subtilis Droge,M.J.; Bos,R.; Boersma,Y.L.; Quax,W.J. Journal of Molecular Catalysis B: Enzymatic. Volume32, Issues 5-6: 261-270.
Composition of the essential oils of Kaempferia rotunda L. and Kaempferia angustifolia Roscoe rhizomes from Indonesia Woerdenbag HJ, Windono T, Bos R, Riswan S, Quax WJ, FLAVOUR AND FRAGRANCE JOURNAL 19 (2): 145-148.
Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production. Kayser O. Olbrich C, Scholer N, Tabatt K, Muller RH. J Pharm Pharmacol. 2004 Jul;56(7):883-91.
FlhF, the third signal recognition particle-GTPase of Bacillus subtilis, is dispensable for protein secretion. Zanen G, Antelmann H, Westers H, Hecker M, van Dijl JM, Quax WJ. J Bacteriol. 2004 Sep;186(17):5956-60.
FlhF, the third signal recognition particle-GTPase of Bacillus subtilis, is dispensable for protein secretion. Zanen G, Antelmann H, Westers H, Hecker M, van Dijl JM, Quax WJ. J Bacteriol. 2004 Sep;186(17):5956-60.
Gene expression profiles of inducible nitric oxide synthase and cytokines in Leishmania major-infected macrophage-like RAW 264.7 cells treated with gallic acid. Kayser, O. Radtke OA, Kiderlen AF, Kolodziej H., Planta Media 2004 Oktober: 70(10), 924-8
Westers H., Braun PG, Westers L, Antelmann H, Hecker M, Jongbloed JDH, Yoshikawa H, Tanaka T, Dijl JM van, Quax, WJ, AEM 1016-04
Improved beta-lactam acylases and their use as industrial biocatalysts. Sio, C.F.; Quax, W.J. Curr Opin Biotechnol. 2004 Aug;15(4):349-55.
Lignan profile of Linum meletonis. Koulman A, Konuklugil B, Biochemical Systematics and Ecology 32 (2004) 91-93
Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption. Kayser O,Olbrich C, Gessner A, Schroder W, Muller RH. J Control Release. 2004 May 18;96(3):425-35.
Modulation of the thoredoxin pathway. Dubois J-Y, Eschevings C, Bron S, Quax WJ, Van Dijl JM, Patent: WO 2004/056987 A1
Mutants and homologs of cephalosproin acylase. Sio, C.F. promotor: Quax, W.J., Rijksuniversiteit Groningen, 2004, 149 pp, ISBN 90-9018672-7
Mutational analysis of a key residue in the substrate specificity of a cephalosporin acylase.
Otten LG, Sio CF, van der Sloot AM, Cool RH, Quax WJ. Chembiochem. 2004 Jun 7;5(6):820-5.
Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications Oliver Kayser (Editor), Rainer H. Müller (Editor) Wiley Publishers February 2004,336 pages
Podophyllotoxin and Related Lignans Produced by plants. Koulman, A., Quax, W.J., Pras, N. Book Biotechnology of medicinal plants (vitalizer and therapeutic) chapter 11, 2004
Post-translocational folding of secretory proteins in Gram-positive bacteria. Sarvas M, Harwood CR, Bron S, van Dijl JM., Biochim Biophys Acta. 2004 Nov 11;1694(1-3):311-27.
Production of enzymes in seeds and their use. Van Ooijen AJJ, Rietveld K, Quax WJ, Pen J, Hoekema A, Sijmons PC, Verwoerd TC, Patent: US 2004/0088750 A1
Tjalsma H, Antelmann H, Jongbloed JD, Braun PG, Darmon E, Dorenbos R, Dubois JY, Westers H, Zanen G, Quax WJ, Kuipers OP, Bron S, Hecker M, van Dijl JM. Microbiol Mol Biol Rev. 2004 Jun;68(2):207-33. Review.
Secretion factors for grampositive micoorganisms, genes encoding them and methods of using it. Quax WJ, Kerkman R, Broekhuizen CP, Patent: US 6,692,951 B2
Selection of novel lipases and esterases for enantioselective biocatalysis
Dröge, M.J. promotor: Quax, W.J., Rijksuniversiteit Groningen, 2004, 176 pp, ISBN 90-901-7661-6
Solid lipid nanoparticles for parenteral drug delivery. Kayser O,Wissing SA, Muller RH. Adv Drug Deliv Rev. 2004 May 7;56(9):1257-72.
Stabilization of TRAIL, an all {beta}-sheet multimeric protein, using computational redesign.
Stabilization of TRAIL, an all {beta}-sheet multimeric protein, using computational redesign.
van der Sloot AM, Mullally MM, Fernandez-Ballester G, Serrano L, Quax WJ. Protein Eng Des Sel. 2004 Oct 14; [Epub ahead of print]
Westers H, Darmon E, Zanen G, Veening JW, Kuipers OP, Bron S, Quax WJ, van Dijl JM.Lett Appl Microbiol. 2004;39(1):65-73.
Thiol-disulfide Oxidoreductases in Bacillus subtilis . Dorenbos, R. promotor: Quax, W.J., Rijksuniversiteit Groningen, 2004, pp 256, ISBN 90-9018901-7.
Two minimal Tat translocases in Bacillus. Jongbloed JD, Grieger U, Antelmann H, Hecker M, Nijland R, Bron S, van Dijl JM., Mol Microbiol. 2004 Dec;54(5):1319-25.
Type I signal peptidases of Gram-positive bacteria. van Roosmalen ML, Geukens N, Jongbloed JD, Tjalsma H, Dubois JY, Bron S, van Dijl JM, Anne J. Biochim Biophys Acta. 2004 Nov 11;1694(1-3):279-97.
| Laatst gewijzigd: | 04 maart 2019 16:11 |